Scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research Foundation (MMRF ...

aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

Saad Usmani, MD, Chief of MSK’s Myeloma Service, says the new combination therapy could be a “big step forward for people with extramedullary myeloma.” Researchers have made great progress in the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

The author challenges the terms "caregiver" and "incurable," suggesting more hopeful alternatives like "Lovegiver" and "can be" or "will be." Advances in multiple myeloma treatments have allowed ...

For the first time, patients with abnormal cells detected in their bone marrow have a treatment option before the condition develops into multiple myeloma. The FDA has approved Johnson & Johnson’s ...

For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms — pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled ...

Researchers found that life expectancy growth in wealthy nations has dramatically slowed since 1939. Once driven by major reductions in child mortality, longevity gains are now limited by slower ...

The author's journey from aspiring oceanographer to architect highlights the transformative power of unexpected life changes. A shift towards Feng Shui and healing spaces followed personal losses, ...